CCLD

Rating neutralAI Memo

CareCloud

As of 2026-09-10/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-09-10 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

neutral

Confidence

medium

Horizon

—

Key catalyst

Execution against FY2026 guidance • 2026-12-31

Base target: $2 / p=50% prob

Biggest risk

Year-over-year profitability weakened, R&D and interest expense are rising, and the AI/compliance growth opportunity remains commercially unproven. Low coverage and unavailable analyst revisions reduce confidence.

Invalidation

Break below $2 or thesis failure.

What would change my mind?

Revenue growth, sustained positive GAAP earnings, reaffirmed FY2026 guidance, AI investment, and potential cross-selling from Empower could support upside if execution converts into operating leverage.

Research note

Recommendation

neutral

Confidence

medium

As of

2026-09-10

Base target

p=50%

Bull target

p=20%

Bear target

p=30%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Mixed Q2 earnings digestion
AI-enabled cross-sell and Empower integration
Revenue growth, sustained positive GAAP earnings, reaffirmed FY2026 guidance, AI investment, and potential cross-selling from Empower could support upside if execution converts into operating leverage.

BearKey bullets

Empower integration and AI-enabled cross-selling may not scale as expected.
GAAP net income and adjusted EBITDA declined year over year despite revenue growth.
Low analyst coverage and limited market-data context increase uncertainty.

WatchKey bullets

Execution against FY2026 guidance

Summary

High-level snapshot

Recommendation

neutral

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Base case: $2 (p=50%)

Target spread vs base: +52% / -29%

Scenario probabilities

Bull Target: $3 (p=20%)Base Target: $2 (p=50%)Bear Target: $2 (p=30%)

Commentary

Cautious, monitoring-style sentiment. Company disclosures are constructive on revenue growth, strategic expansion, and guidance reaffirmation, but weaker profitability offsets that signal [#SEC-8K-2026-08-06]. Recent coverage is sparse, and analyst revisions, reliable post-release market reaction, social coverage, options skew, short interest, and employee data are unavailable; missing data lowers confidence rather than providing positive evidence.

As of 2026-09-10 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

Mixed Q2 earnings digestion
AI-enabled cross-sell and Empower integration

Scenarios

Bull Target (Scenario probability)

$3 / p=20% prob

Base Target (Scenario probability)

$2 / p=50% prob

Bear Target (Scenario probability)

$2 / p=30% prob

Analysis 2026-09-10 · RankAlpha Sentiment Codex

Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)

0.00

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-12-31
Execution against FY2026 guidance
Delivery of reaffirmed FY2026 revenue guidance of $128-$132 million, adjusted EBITDA of $29-$31 million, and GAAP EPS of $0.20-$0.23 could validate the operating thesis [#SEC-8K-2026-08-06].
Prob 50.00% • Move 12.00% • Priced-in 50.00%

Short-term Catalysts

Next few weeks

Mixed Q2 earnings digestion
2026-12-09
Q2 revenue increased 16% year over year to $31.9 million and full-year guidance was reaffirmed, but GAAP net income and adjusted EBITDA declined year over year, supporting cautious near-term monitoring [#SEC-8K-2026-08-06].
Prob 70% • Move -5% • Priced-in 70%

Long-term Catalysts

Months to a year

AI-enabled cross-sell and Empower integration
2027-09-10
The Empower acquisition expands CareCloud into compliance and audit defense across a network of more than 40,000 providers, while management is investing in AI-enabled offerings; commercial conversion and timing remain uncertain [#PR-EARNINGS-2026-08-13].
Prob 40% • Move 20% • Priced-in 25%

Risks

Empower integration and AI-enabled cross-selling may not scale as expected.
GAAP net income and adjusted EBITDA declined year over year despite revenue growth.
Low analyst coverage and limited market-data context increase uncertainty.
R&D investment and higher interest expense may delay margin expansion.
Reaffirmed FY2026 guidance remains execution-dependent.

Peers

Symbol	Summary
GUTS	Same-sector small-cap screen candidate; direct operating and valuation comparability is not established in the packet.
KEQU	Same-sector small-cap screen candidate; direct operating and valuation comparability is not established in the packet.
MBOT	Same-sector small-cap screen candidate; direct operating and valuation comparability is not established in the packet.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-09-10

Loading AI feed…

Symbol

Summary

GUTS

Same-sector small-cap screen candidate; direct operating and valuation comparability is not established in the packet.

KEQU

Same-sector small-cap screen candidate; direct operating and valuation comparability is not established in the packet.

MBOT

Same-sector small-cap screen candidate; direct operating and valuation comparability is not established in the packet.